Which pathway addresses andropause?
Andropause symptoms with confirmed low testosterone route to TRT. Candidates prioritizing fertility may be routed to enclomiphene as an HPG-axis-preserving alternative.
Full answer
Andropause describes the symptomatic, biomarker-confirmed decline in testosterone seen in many men with age. Provider review confirms low total and free testosterone on two morning draws and screens cardiovascular, prostate, and hematocrit context. TRT is the primary pathway. Candidates prioritizing fertility, or wanting to preserve their own HPG axis, are evaluated for enclomiphene as an alternative. Every initiation requires the standardized biomarker panel and synchronous video review with recalibration at 8–12 weeks.
Educational. Not a substitute for individualized provider review.
- Testosterone Optimization pathway — Primary source · oMeds
- Reviewed by Dr. Laura Purdy, MD, MBA · Clinical Director, oMeds · Last reviewed 2026-05-29